Biomarkers in Angina

References

• Collinson P. O., Rao A. C., Canepa‐anson R., Joseph S. Impact of European Society of Cardiology/American College of Cardiology guidelines on diagnostic classification of patients with suspected acute coronary syndromes. Ann.Clin.Biochem. 2003; 40: 156–60
   PubMedGoogle Scholar
• Refsum H., Smith A. D., Ueland P. M., Nexo E., Clarke R., Mcpartlin J. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin.Chem. 2004; 50: 3–32
   PubMed Web of Science ®Google Scholar
• Walldius G., Jungner I., Holme I., Aastveit A. H., Kolar W., Steiner E. High apolipoprotein B, low apolipoprotein A‐I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001; 358: 2026–33
   PubMed Web of Science ®Google Scholar
• Williams K., Sniderman A. D., Sattar N., D'agostino R, Jr., Wagenknecht L. E., Haffner S. M. Comparison of the associations of apolipoprotein B and low‐density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2003; 108: 2312–6
   PubMed Web of Science ®Google Scholar
• Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case‐control study. Lancet 2004; 364: 937–52
   PubMed Web of Science ®Google Scholar
• Rioufol G., Finet G., Ginon I., Andre‐fouet X., Rossi R., Vialle E. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three‐vessel intravascular ultrasound study. Circulation 2002; 106: 804–8
   PubMed Web of Science ®Google Scholar
• Hong M. K., Mintz G. S., Lee C. W., Kim Y. H., Lee S. W., Song J. M. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three‐vessel intravascular ultrasound study in 235 patients. Circulation 2004; 110: 928–33
   PubMed Web of Science ®Google Scholar
• Ridker P. M., Rifai N., Rose L., Buring J. E., Cook N. R. Comparison of C‐reactive protein and low‐density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N.Engl.J.Med. 2002; 347: 1557–65
   PubMed Web of Science ®Google Scholar
• Ridker P. M. Clinical application of C‐reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363–9
   PubMed Web of Science ®Google Scholar
• Rifai N., Ridker P. M. High‐sensitivity C‐reactive protein: a novel and promising marker of coronary heart disease. Clin.Chem. 2001; 47: 403–11
   PubMed Web of Science ®Google Scholar
• Koenig W., Lowel H., Baumert J., Meisinger C. C‐reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 2004; 109: 1349–53
   PubMed Web of Science ®Google Scholar
• Cannon C. P., Braunwald E., Mccabe C. H., Rader D. J., Rouleau J. L., Belder R. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N. Engl. J. Med. 2004; 350: 1495–504
   PubMed Web of Science ®Google Scholar
• Ridker P. M., Cannon C. P., Morrow D., Rifai N., Rose L. M., Mccabe C. H. C‐reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 2005; 352: 20–8
   PubMed Web of Science ®Google Scholar
• Zouridakis E., Avanzas P., Arroyo‐espliguero R., Fredericks S., Kaski J. C. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004; 110: 1747–53
   PubMed Web of Science ®Google Scholar
• Hong M. K., Mintz G. S., Lee C. W., Kim Y. H., Lee S. W., Song J. M. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three‐vessel intravascular ultrasound study in 235 patients. Circulation 2004; 110: 928–33
   PubMed Web of Science ®Google Scholar
• James S. K., Lindahl B., Siegbahn A., Stridsberg M., Venge P., Armstrong P. N‐terminal pro‐brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV substudy. Circulation 2003; 108: 275–81
   PubMed Web of Science ®Google Scholar
• Kragelund C., Gronning B., Kober L., Hildebrandt P., Steffensen R. N‐terminal pro‐B‐type natriuretic peptide and long‐term mortality in stable coronary heart disease. N.Engl.J.Med. 2005; 352: 666–75
   PubMed Web of Science ®Google Scholar
• Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 2002; 359: 1269–75
   PubMed Web of Science ®Google Scholar
• Apple F. S., Wu A. H., Mair J., Ravkilde J., Panteghini M., Tate J. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin.Chem. 2005; 51: 810–24
   PubMed Web of Science ®Google Scholar
• Bar‐or D., Curtis G., Rao N., Bampos N., Lau E. Characterization of the Co(2+) and Ni(2+) binding aminoacid residues of the N‐terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur.J.Biochem. 2001; 268: 42–7
   PubMedGoogle Scholar
• Laussac J. P., Sarkar B. Characterization of the copper(II)‐ and nickel(II)‐transport site of human serum albumin. Studies of copper(II) and nickel(II) binding to peptide 1–24 of human serum albumin by 13C and 1H NMR spectroscopy. Biochemistry 1984; 23: 2832–8
   PubMed Web of Science ®Google Scholar
• Chevion M., Jiang Y., Har‐el R., Berenshtein E., Uretzky G., Kitrossky N. Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. Proc.Natl.Acad.Sci.U.S.A 1993; 90: 1102–6
   PubMed Web of Science ®Google Scholar
• Sinha M. K., Gaze D. C., Tippins J. R., Collinson P. O., Kaski J. C. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003; 107: 2403–5
   PubMed Web of Science ®Google Scholar
• Garrido I. P., Roy D., Calvino R., Vazquez‐rodriguez J. M., Aldama G., Cosin‐sales J. Comparison of ischemia‐modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am.J.Cardiol. 2004; 93: 88–90
   PubMed Web of Science ®Google Scholar
• Quiles J., Roy D., Gaze D., Garrido I. P., Avanzas P., Sinha M. Relation of ischemia‐modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon‐induced myocardial ischemia. Am.J.Cardiol. 2003; 92: 322–4
   PubMedGoogle Scholar
• Roy D., Quiles J., Sinha M., Aldama G., Gaze D., Kaski J. C. Effect of direct‐current cardioversion on ischemia‐ modified albumin levels in patients with atrial fibrillation. Am.J.Cardiol. 2004; 93: 366–8
   PubMed Web of Science ®Google Scholar
• Christenson R. H., Duh S. H., Sanhai W. R., Wu A. H., Holtman V., Painter P. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin.Chem. 2001; 47: 464–70
   PubMed Web of Science ®Google Scholar
• Bhagavan N. V., Lai E. M., Rios P. A., Yang J., Ortega‐lopez A. M., Shinoda H. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin.Chem. 2003; 49: 581–5
   PubMed Web of Science ®Google Scholar
• Roy D., Quiles J., Aldama G., Sinha M., Avanzas P., Arroyo‐espliguero R. Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non‐diagnostic 12‐lead electrocardiograms and negative cardiac troponin T. Int.J.Cardiol. 2004; 97: 297–301
   PubMed Web of Science ®Google Scholar
• Sinha M. K., Roy D., Gaze D. C., Collinson P. O., Kaski J. C. Role of “Ischemia Modified Albumin”, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg.Med.J. 2004; 21: 29–34
   PubMed Web of Science ®Google Scholar
• Bassan R., Potsch A., Maisel A., Tura B., Villacorta H., Nogueira M. V. B‐type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST‐segment elevation. Eur.Heart J. 2005; 26: 234–40
   PubMed Web of Science ®Google Scholar